Equities

Zinzino AB

Zinzino AB

Actions
  • Price (SEK)73.80
  • Today's Change2.60 / 3.65%
  • Shares traded19.54k
  • 1 Year change+75.71%
  • Beta1.3180
Data delayed at least 15 minutes, as of Apr 26 2024 17:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Zinzino AB is a Sweden-based global Company engaged in selling dietary supplements, skin care and lifestyle products. The Company specializes in biomarker-based, personalized nutrition and health tech. The Company’s test-based, scientifically proven nutritional supplements are available on more than 100 markets across the world. Zinzino AB owns the Norwegian research and production units BioActive Foods AS and Faun Pharma AS. The Company’s headquarter is in Gothenburg, Sweden with additional offices in Finland, Latvia, Norway, USA, Australia, Hong Kong, Malaysia and India.

  • Revenue in SEK (TTM)1.67bn
  • Net income in SEK163.74m
  • Incorporated2007
  • Employees207.00
  • Location
    Zinzino ABHulda Mellgrens gata 5VAESTRA FROELUNDA 421 32SwedenSWE
  • Phone+46 3177171
  • Fax+46 317269976
  • Websitehttps://www.zinzino.com/
More ▼

Institutional shareholders

1.08%Per cent of shares held by top holders
HolderShares% Held
LOYS AGas of 30 Jun 2023269.60k0.94%
Acadian Asset Management LLCas of 29 Feb 202413.76k0.05%
Alphajet Fair Investors SASas of 16 Apr 202412.00k0.04%
Victory Capital Management, Inc. (Investment Management)as of 31 Jan 20244.93k0.02%
J. Chahine Capital SAas of 29 Feb 20243.59k0.01%
PFM Asset Management LLCas of 31 Dec 20233.18k0.01%
AIFM Capital ABas of 31 Dec 20212.92k0.01%
Lazard Asset Management LLCas of 31 Mar 20241.56k0.01%
Sepiam SASas of 30 Jun 20220.000.00%
Deka Investment GmbHas of 30 Sep 20230.000.00%
More ▼
Data from 31 Dec 2021 - 16 Apr 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.